Press Briefing on WHO PQ of Swiss Pharma{Swipha}‘s Second Product Antimalarial: Sulfadoxine/Pyrimethanine Tablets {SP Combination}
PROTOCOL The National Agency for Food and Drug Administration and Control (NAFDAC) was set up by act of the parliament (Act Cap N1 LFN 2004 as amended) to regulate and control the manufacture, importation, exportation, distribution, advertisement, sale and use of Food, Drugs, Cosmetics, Medical Devices, Packaged Water, Chemicals and Detergents” (collectively known as regulated […]
Remarks and Talking Points of Prof. Mojisola Christianah Adeyeye Phd, Fas; at the NAFDAC Export Stakeholder Interactive Session on NAFDAC Export Regulations
Remarks by Prof. Adeyeye C M, Director General NAFDAC NAFDAC Export Stakeholder Interactive Session on NAFDAC Export Regulations NAFDAC PID Conference Centre, Yaba, Lagos 20th May, 2024. PROTOCOLI was quite curious to find out today what exactly the Cocoa Stakeholders are concerned with, especially in the draft Cocoa regulations we have posted for comments. First, let […]
Public Alert No. 031/2024 – Illegal Sale of Substandard and Falsified (SF) Colamar (Artemether/Lumefantrine 20/120mg) Oral Suspension
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the public of the illegal distribution and marketing of a substandard and falsified anti-malaria, Colamar (Artemether/Lumefantrine 20/120mg). The Substandard and falsified product is a pass-off of Lonart Suspension and has a fake NAFDAC Registration Number (NRN): B4-4065 which is a registration number of Malasyn Tablets […]
Public Alert No. 030/2024 – Alert on Confirmed Counterfeit of Avastin in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeit of Avastin in Nigeria. The Marketing Authorization Holder (MAH) Roche reported that an oncologist from a local hospital raised the suspicion for counterfeited material of Avastin Vials 400 mg/16 ml, batch […]
Public Alert No. 029/2024 – Alert on Confirmed Counterfeit of Tecentriq Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeits of Tecentriq injection in Nigeria. The Marketing Authorization Holder (MAH) Roche reported that an oncologist from a local hospital raised the suspicion for counterfeited material of Tecentriq Vials 1200 mg/20 ml, […]
Public Alert No. 028/2024 – Alert on Confirmed Counterfeits of Perjeta in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeits of Perjeta in Nigeria. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting two units of suspected counterfeit Roche products, Perjeta 420 mg/14mL. For the technical investigation, […]
Public Alert No. 027/2024 – Alert on Confirmed Counterfeit of Herceptin in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) informs the healthcare providers and the public of a report of Confirmed Counterfeit of Herceptin in Nigeria. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting two units of suspected counterfeit Roche product, Herceptin 600 mg/5 ml. For the technical […]
Public Notice No. 026/2024 – Notice to Uninstall and Reinstall Med Safety App Important Update for Med Safety App Users
Dear Valued Users, We hope this message finds you well. We are excited to announce that several important updates have been rolled out for the Med Safety App, enhancing its functionality and user experience. These updates include vital bug fixes and improvements that have been developed and deployed over the years. To ensure you receive […]
Public Alert No. 025/2024 – Alert on the Sale of Counterfeit PHESGO 600mg/10ml Injection in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) wishes to inform healthcare providers and the public of a report of a suspected counterfeit of Phesgo® 600mg/600mg, labeled with batch C3809C51. The Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting a suspected counterfeit Phesgo® 600mg/600mg, labeled with batch C3809C51. […]
Public Alert No. 024/2024 – Alert on Recall of Herbal Dietary Supplement by Stop-Clopez Corp. Due to Undeclared Nortadalafil
The National Agency for Food and Drugs Administration and Control (NAFDAC) is notifying the public of a voluntary recall of one lot of Schwinnng capsules by Stop Clopex Corp, due to the undeclared presence of Nortadalafil. The product was found to contain Nortadalafil, during an FDA analysis. Nortadalafil is an active drug ingredient known for […]
